stock rating
Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating
PacBio's recent acquisition of Omniome, a short-read sequencing technology firm, is "a true game changer," Canaccord Genuity analyst Kyle Mikson said.
Twist Bioscience, Adicet Bio Ink Cancer Collaboration; Barclays Initiates Twist Coverage
Twist will provide its single-chain variable fragment and single-domain VHH antibody (nanobody) technologies to discover unique target-specific binders.
Piper Sandler Initiates Coverage of Cytek Biosciences With Overweight Rating
The investment bank said that Cytek was well positioned to remain one of the fastest growing life science tools companies, thanks to its light-based cell analysis technology.
JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings
Both investment banks are bullish on the genomic data analysis firm, which went public on the Nasdaq a month ago, raising $234 million in gross proceeds.
Hologic Upgraded to Outperform by Evercore ISI
Investors are refocusing on Hologic's base business given an anticipated major cut to COVID-19 industry testing revenues in fiscal year 2022, according to Evercore.